Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII) is listed on NASDAQ in the Finance, Insurance & Real Estate sector. This page tracks real-time DMII price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $4.3M
EPS --
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition II LLC | 10% Owner | Buy | 7,266,667 | $0.00 | $0 | 2025 Sep 26 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Buy | 7,266,667 | $0.00 | $0 | 2025 Sep 26 |
Other Bank Stocks
- JPM JP Morgan Chase & Co.
- BAC Bank of America Corporation
- WFC Wells Fargo & Company
- YHNA YHN Acquisition I Limited - Ordinary Shares
- TVIV Texas Ventures Acquisition IV Corp - Class A Ordinary Shares
- IPEX Inflection Point Acquisition Corp. - Class A Ordinary Shares
- WENC West Enclave Merger Corp. Ordinary Shares
- OACC Oaktree Acquisition Corp. III Life Sciences - Class A Ordinary Share
Take DMII further
- Browse Bank Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DMII in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Drugs Made In America Acquisition II Corp. - Ordinary Shares next reports.
Set alerts on DMII
Get notified when Drugs Made In America Acquisition II Corp. - Ordinary Shares hits your price targets or technical conditions are met.
Get Started Free